168 related articles for article (PubMed ID: 12760419)
1. Inhibition of neurotransmitter release by peptides that mimic the N-terminal domain of SNAP-25.
Apland JP; Adler M; Oyler GA
J Protein Chem; 2003 Feb; 22(2):147-53. PubMed ID: 12760419
[TBL] [Abstract][Full Text] [Related]
2. Peptides that mimic the carboxy-terminal domain of SNAP-25 block acetylcholine release at an Aplysia synapse.
Apland JP; Biser JA; Adler M; Ferrer-Montiel AV; Montal M; Canaves JM; Filbert MG
J Appl Toxicol; 1999 Dec; 19 Suppl 1():S23-6. PubMed ID: 10594895
[TBL] [Abstract][Full Text] [Related]
3. Modulation of L-type Ca(2+) channels by distinct domains within SNAP-25.
Ji J; Yang SN; Huang X; Li X; Sheu L; Diamant N; Berggren PO; Gaisano HY
Diabetes; 2002 May; 51(5):1425-36. PubMed ID: 11978639
[TBL] [Abstract][Full Text] [Related]
4. Importance of two adjacent C-terminal sequences of SNAP-25 in exocytosis from intact and permeabilized chromaffin cells revealed by inhibition with botulinum neurotoxins A and E.
Lawrence GW; Foran P; Mohammed N; DasGupta BR; Dolly JO
Biochemistry; 1997 Mar; 36(11):3061-7. PubMed ID: 9115981
[TBL] [Abstract][Full Text] [Related]
5. Uptake of botulinum neurotoxin into cultured neurons.
Keller JE; Cai F; Neale EA
Biochemistry; 2004 Jan; 43(2):526-32. PubMed ID: 14717608
[TBL] [Abstract][Full Text] [Related]
6. The role of the synaptic protein snap-25 in the potency of botulinum neurotoxin type A.
Keller JE; Neale EA
J Biol Chem; 2001 Apr; 276(16):13476-82. PubMed ID: 11278807
[TBL] [Abstract][Full Text] [Related]
7. The 26-mer peptide released from SNAP-25 cleavage by botulinum neurotoxin E inhibits vesicle docking.
Ferrer-Montiel AV; Gutiérrez LM; Apland JP; Canaves JM; Gil A; Viniegra S; Biser JA; Adler M; Montal M
FEBS Lett; 1998 Sep; 435(1):84-8. PubMed ID: 9755864
[TBL] [Abstract][Full Text] [Related]
8. Distinct exocytotic responses of intact and permeabilised chromaffin cells after cleavage of the 25-kDa synaptosomal-associated protein (SNAP-25) or synaptobrevin by botulinum toxin A or B.
Lawrence GW; Foran P; Dolly JO
Eur J Biochem; 1996 Mar; 236(3):877-86. PubMed ID: 8665909
[TBL] [Abstract][Full Text] [Related]
9. Truncated SNAP-25 (1-197), like botulinum neurotoxin A, can inhibit insulin secretion from HIT-T15 insulinoma cells.
Huang X; Wheeler MB; Kang YH; Sheu L; Lukacs GL; Trimble WS; Gaisano HY
Mol Endocrinol; 1998 Jul; 12(7):1060-70. PubMed ID: 9658409
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons.
Foran PG; Mohammed N; Lisk GO; Nagwaney S; Lawrence GW; Johnson E; Smith L; Aoki KR; Dolly JO
J Biol Chem; 2003 Jan; 278(2):1363-71. PubMed ID: 12381720
[TBL] [Abstract][Full Text] [Related]
11. Presynaptic protein interactions in vivo: evidence from botulinum A, C, D and E action at frog neuromuscular junction.
Raciborska DA; Trimble WS; Charlton MP
Eur J Neurosci; 1998 Aug; 10(8):2617-28. PubMed ID: 9767392
[TBL] [Abstract][Full Text] [Related]
12. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25.
Blasi J; Chapman ER; Link E; Binz T; Yamasaki S; De Camilli P; Südhof TC; Niemann H; Jahn R
Nature; 1993 Sep; 365(6442):160-3. PubMed ID: 8103915
[TBL] [Abstract][Full Text] [Related]
13. Common and distinct fusion proteins in axonal growth and transmitter release.
Osen-Sand A; Staple JK; Naldi E; Schiavo G; Rossetto O; Petitpierre S; Malgaroli A; Montecucco C; Catsicas S
J Comp Neurol; 1996 Apr; 367(2):222-34. PubMed ID: 8708006
[TBL] [Abstract][Full Text] [Related]
14. Botulinum neurotoxin A and neurotoxin E cleavage products of synaptosome-associated protein of 25 kd exhibit distinct actions on pancreatic islet beta-cell Kv2.1 channel gating.
He Y; Elias CL; Huang YC; Gao X; Leung YM; Kang Y; Xie H; Chaddock JA; Tsushima RG; Gaisano HY
Pancreas; 2008 Jan; 36(1):10-7. PubMed ID: 18192874
[TBL] [Abstract][Full Text] [Related]
15. Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage.
Vaidyanathan VV; Yoshino K; Jahnz M; Dörries C; Bade S; Nauenburg S; Niemann H; Binz T
J Neurochem; 1999 Jan; 72(1):327-37. PubMed ID: 9886085
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effectiveness of botulinum neurotoxin A: potent blockade of autonomic transmission by targeted cleavage of only the pertinent SNAP-25.
Lawrence GW; Ovsepian SV; Wang J; Aoki KR; Dolly JO
Neuropharmacology; 2013 Jul; 70():287-95. PubMed ID: 23485402
[TBL] [Abstract][Full Text] [Related]
17. Fusion of Golgi-derived vesicles mediated by SNAP-25 is essential for sympathetic neuron outgrowth but relatively insensitive to botulinum neurotoxins in vitro.
Lawrence GW; Wang J; Brin MF; Aoki KR; Wheeler L; Dolly JO
FEBS J; 2014 Jul; 281(14):3243-60. PubMed ID: 24863955
[TBL] [Abstract][Full Text] [Related]
18. Multiple domains of botulinum neurotoxin contribute to its inhibition of transmitter release in Aplysia neurons.
Poulain B; Wadsworth JD; Shone CC; Mochida S; Lande S; Melling J; Dolly JO; Tauc L
J Biol Chem; 1989 Dec; 264(36):21928-33. PubMed ID: 2574722
[TBL] [Abstract][Full Text] [Related]
19. Persistence of botulinum neurotoxin A demonstrated by sequential administration of serotypes A and E in rat EDL muscle.
Adler M; Keller JE; Sheridan RE; Deshpande SS
Toxicon; 2001; 39(2-3):233-43. PubMed ID: 10978741
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of synaptic neurotransmitter release mechanisms using bacterial toxins].
Doussau F; Humeau Y; Vitiello F; Popoff MR; Poulain B
J Soc Biol; 1999; 193(6):457-67. PubMed ID: 10783704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
